Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
United Therapeutics (UTHR)
NASDAQ:UTHR
United Therapeutics (UTHR) Ownership Overview
7.08% Insiders
25.89% Mutual Funds
0.54% Other Institutional Investors
27.74% ETFs
38.75% Public Companies and Individual Investors
The ownership structure of United Therapeutics (UTHR) stock is a mix of institutional, retail, and individual investors. Approximately 54.17% of the company’s stock is owned by Institutional Investors, 7.08% is owned by Insiders, and 38.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | Nilda Mesa Director | xxxxxxxxxxxxx | $90719 |
| Dec 19, 2024 | Louis Sullivan Director | xxxxxxxxxxxxx | $9781598 |
| Dec 10, 2024 | Michael Benkowitz President & Coo | xxxxxxxxxxxxx | $223661 |
| Nov 12, 2024 | Nilda Mesa Director | xxxxxxxxxxxxx | $92348 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $2963856 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $5765052 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $46521954 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,690,691 | Institution | 10.51% | 1,738,276,271 | |
| 4,287,654 | Institution | 9.60% | 1,588,918,819 | |
| 3,942,485 | Institution | 8.83% | 1,461,006,091 | |
| 3,194,162 | Insider | 6.80% | 1,183,692,554 | |
| 1,163,479 | Institution | 2.61% | 431,162,048 | |
| 942,664 | Institution | 2.11% | 349,332,425 | |
| 903,467 | Institution | 2.02% | 334,806,801 | |
| 608,403 | Institution | 1.36% | 225,461,984 | |
| 584,551 | Institution | 1.31% | 216,622,910 | |
| 482,270 | Institution | 1.08% | 178,719,617 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,942,485 | Institution | 8.83% | 1,461,006,091 | |
| 942,664 | Institution | 2.11% | 349,332,425 | |
| 903,467 | Institution | 2.02% | 334,806,801 | |
| 584,551 | Institution | 1.31% | 216,622,910 | |
| 482,270 | Institution | 1.08% | 178,719,617 | |
| 362,503 | Institution | 0.81% | 134,336,362 | |
| 315,411 | Institution | 0.71% | 116,885,008 | |
| 206,597 | Institution | 0.46% | 76,560,716 | |
| 191,641 | Institution | 0.43% | 71,018,322 | |
| 170,186 | Institution | 0.38% | 63,067,528 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,444,410 | Institution | 3.24% | 535,067,240 | |
| 1,415,777 | Institution | 3.17% | 301,546,343 | |
| 1,400,359 | Institution | 3.14% | 494,102,670 | |
| 1,136,864 | Institution | 2.55% | 401,131,094 | |
| 754,751 | Institution | 1.69% | 266,306,343 | |
| 676,119 | Institution | 1.51% | 238,561,828 | |
| 566,183 | Institution | 1.27% | 209,906,685 | |
| 397,892 | Institution | 0.89% | 147,395,112 | |
| 363,729 | Institution | 0.81% | 134,739,771 | |
| 275,166 | Institution | 0.62% | 101,932,493 |
FAQ
Who Owns United Therapeutics (UTHR)?
According to the latest TipRanks data, approximately 0.54% of the company's stock is held by institutional investors, 7.08% is held by insiders, and 38.75% is held by retail investors.
What percentage of United Therapeutics (UTHR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.54% of United Therapeutics (UTHR) stock is held by institutional investors.
What percentage of United Therapeutics (UTHR) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.75% of United Therapeutics (UTHR) stock is held by retail investors.
Who owns the most shares of United Therapeutics (UTHR)?
iShares owns the most shares of United Therapeutics (UTHR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.